Bor‐Ru Lin
Impact in
- Molecular Medicine top 0.2%
- Curcumin's Biomedical Applications
- Drug Discovery top 10%
Papers in
-
- Gastroesophageal reflux and treatments 6
-
- Platelet Disorders and Treatments 8
- Co-authors
- Jiiang‐Huei Jeng (18 shared papers)Mei‐Chi Chang (18 shared papers)Chiu‐Po Chan (7 shared papers)Liang‐Jiunn Hahn (4 shared papers)Chia‐Tung Shun (7 shared papers)Yi‐Jane Chen (6 shared papers)Jang‐Jaer Lee (5 shared papers)Ying‐Jan Wang (5 shared papers)
- Journals
- Gastroenterology (5 papers)PLoS ONE (3 papers)Journal of Oral Pathology and Medicine (2 papers)Toxicology (2 papers)Atherosclerosis (2 papers)
- Partner nations
- TaiwanUnited StatesJapan
In The Last Decade
Bor‐Ru Lin
42 papers receiving 3.3k citations
Bor‐Ru Lin's Hit Papers
Peers
Comparison fields: 5 of 116
- Molecular Medicine 1.2k
- Drug Discovery 9
- Periodontics 187
- Biochemistry 156
- Pharmacology 213
Countries citing papers authored by Bor‐Ru Lin
This map shows the geographic impact of Bor‐Ru Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bor‐Ru Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bor‐Ru Lin more than expected).
Fields of papers citing papers by Bor‐Ru Lin
This network shows the impact of papers produced by Bor‐Ru Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bor‐Ru Lin. The network helps show where Bor‐Ru Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Bor‐Ru Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 42 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Hit paper breakdown → | 2001 | 1862 |
| 2 | 2014 | 177 | |
| 3 | 2004 | 121 | |
| 4 | 1999 | 95 | |
| 5 | 2012 | 78 | |
| 6 | 2006 | 77 | |
| 7 | 2009 | 72 | |
| 8 | 2006 | 63 | |
| 9 | 2002 | 59 | |
| 10 | 2004 | 57 | |
| 11 | 2014 | 56 | |
| 12 | 2004 | 53 | |
| 13 | 2003 | 51 | |
| 14 | 2004 | 49 | |
| 15 | 2007 | 49 | |
| 16 | 2011 | 47 | |
| 17 | 2014 | 45 | |
| 18 | 2011 | 43 | |
| 19 | 2000 | 39 | |
| 20 | 2019 | 33 |
About Bor‐Ru Lin
Bor‐Ru Lin is a scholar working on Gastroenterology, Hematology, Pharmacology, Pharmacology and Surgery, having authored 42 papers that have together received 3.4k indexed citations. Recurring topics across this work include Helicobacter pylori-related gastroenterology studies (9 papers), Platelet Disorders and Treatments (8 papers), Inflammatory mediators and NSAID effects (6 papers), Gastroesophageal reflux and treatments (6 papers), Oral Health Pathology and Treatment (3 papers), Drug-Induced Hepatotoxicity and Protection (3 papers), Nitric Oxide and Endothelin Effects (2 papers) and Cancer and biochemical research (2 papers). The work is most often cited by research in Molecular Medicine (1.2k citations), Drug Discovery (9 citations), Periodontics (187 citations), Biochemistry (156 citations) and Pharmacology (213 citations). Bor‐Ru Lin has collaborated with scholars based in Taiwan, United States and Japan. Frequent co-authors include Jiiang‐Huei Jeng, Mei‐Chi Chang, Chiu‐Po Chan, Liang‐Jiunn Hahn, Chia‐Tung Shun, Yi‐Jane Chen, Jang‐Jaer Lee, Ying‐Jan Wang, Chiang‐Ting Chien and Jyh‐Chin Yang. Their work appears in journals such as Gastroenterology, PLoS ONE, Journal of Oral Pathology and Medicine, Toxicology and Atherosclerosis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.